Effect of Corticosteroid Treatment on Prognosis in ARDS Secondary to Covid-19 — CoCovSDRA  

Acute Respiratory Distress Syndrome Secondary to Covid-19 Clinical Trial

Official title: Effect of Early Corticosteroid Therapy on Mortality in Patient With Acute Respiratory Distress Syndrome Secondary to Covid-19

Status Active, not recruiting

Clinical Trial Summary

Study conducted on hospitalized patient in critical ill units in Nancy and Metz to evaluate if early corticosteroid treatment in first seven days after admission improve patients outcome in Acute Respiratory Distress Syndrome secondary to Covid-19 compared to later corticosteroid therapy or no treatment. Also comparison of acquired infection with or without corticosteroid treatment during hospitalisation.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Acute Lung Injury
• Acute Respiratory Distress Syndrome Secondary to Covid-19
• Neoplasm Metastasis
• Respiratory Distress Syndrome, Adult
• Respiratory Distress Syndrome, Newborn
• Syndrome

• NCT number: NCT04586114
• Study type: Observational
• Source: Central Hospital, Nancy, France
• Status: Active, not recruiting
• Start date: March 1, 2020
• Completion date: December 31, 2020